Is AIT safe to use with an active malignancy such as CTCL?

I'm not aware of any evidence to suggest that AIT would not be safe in stable patients with CTCL, although there are no studies either. If the patient is immune compromised there is a possibility that allergen immunotherapy would be less effective. The main concern with safety would be having to come into the office at least weekly, and therefore having increased risk for infection by exposure to other patients, etc.

I hope that helps.